» Articles » PMID: 11704974

Animal Models for Osteoporosis

Overview
Publisher Springer
Specialty Endocrinology
Date 2001 Nov 14
PMID 11704974
Citations 61
Authors
Affiliations
Soon will be listed here.
Abstract

Animal models will continue to be important tools in the quest to understand the contribution of specific genes to establishment of peak bone mass and optimal bone architecture, as well as the genetic basis for a predisposition toward accelerated bone loss in the presence of co-morbidity factors such as estrogen deficiency. Existing animal models will continue to be useful for modeling changes in bone metabolism and architecture induced by well-defined local and systemic factors. However, there is a critical unfulfilled need to develop and validate better animal models to allow fruitful investigation of the interaction of the multitude of factors which precipitate senile osteoporosis. Well characterized and validated animal models that can be recommended for investigation of the etiology, prevention and treatment of several forms of osteoporosis have been listed in Table 1. Also listed are models which are provisionally recommended. These latter models have potential but are inadequately characterized, deviate significantly from the human response, require careful choice of strain or age, or are not practical for most investigators to adopt. It cannot be stressed strongly enough that the enormous potential of laboratory animals as models for osteoporosis can only be realized if great care is taken in the choice of an appropriate species, age, experimental design, and measurements. Poor choices will results in misinterpretation of results which ultimately can bring harm to patients who suffer from osteoporosis by delaying advancement of knowledge.

Citing Articles

Administration of Young Coconut ( L.) Juice Ameliorates Memory Impairment in a Menopausal Rat Model.

Sugiyama S, Matsushita H, Minami A, Nakao H, Hata S, Matsumoto A Diseases. 2024; 12(10).

PMID: 39452493 PMC: 11507406. DOI: 10.3390/diseases12100250.


Effects of stepwise administration of osteoprotegerin and parathyroid hormone-related peptide DNA vectors on bone formation in ovariectomized rat model.

Eom Y, Kim J, Rim Y, Lim J, Jung S, Ju J Sci Rep. 2024; 14(1):2477.

PMID: 38291053 PMC: 10827729. DOI: 10.1038/s41598-024-51957-0.


The Effect of Supplement on Bone Mineral Density in Ovariectomy-induced Osteoporosis in Rats.

Neri A, Galanis D, Galanos A, Pepe A, Soultanis K, Zervas A In Vivo. 2023; 37(1):270-285.

PMID: 36593044 PMC: 9843798. DOI: 10.21873/invivo.13077.


Application of metabolomics in osteoporosis research.

Zhao Z, Cai Z, Chen A, Cai M, Yang K Front Endocrinol (Lausanne). 2022; 13:993253.

PMID: 36452325 PMC: 9702081. DOI: 10.3389/fendo.2022.993253.


Protective Effect on Bone of Nacre Supplementation in Ovariectomized Rats.

Nguyen D, Laroche N, Vanden-Bossche A, Linossier M, Thomas M, Peyroche S JBMR Plus. 2022; 6(9):e10655.

PMID: 36111203 PMC: 9464996. DOI: 10.1002/jbm4.10655.


References
1.
Gluer C . Monitoring skeletal changes by radiological techniques. J Bone Miner Res. 1999; 14(11):1952-62. DOI: 10.1359/jbmr.1999.14.11.1952. View

2.
Goulding A, Gold E . A new way to induce oestrogen-deficiency osteopaenia in the rat: comparison of the effects of surgical ovariectomy and administration of the LHRH agonist buserelin on bone resorption and composition. J Endocrinol. 1989; 121(2):293-8. DOI: 10.1677/joe.0.1210293. View

3.
Jordan V, Phelps E, Lindgren J . Effects of anti-estrogens on bone in castrated and intact female rats. Breast Cancer Res Treat. 1987; 10(1):31-5. DOI: 10.1007/BF01806132. View

4.
Rantakokko J, Uusitalo H, Jamsa T, Tuukkanen J, Aro H, Vuorio E . Expression profiles of mRNAs for osteoblast and osteoclast proteins as indicators of bone loss in mouse immobilization osteopenia model. J Bone Miner Res. 1999; 14(11):1934-42. DOI: 10.1359/jbmr.1999.14.11.1934. View

5.
Wronski T, Lowry P, Walsh C, Ignaszewski L . Skeletal alterations in ovariectomized rats. Calcif Tissue Int. 1985; 37(3):324-8. DOI: 10.1007/BF02554882. View